The global radiodermatitis market is primarily driven by the rising prevalence of cancer globally. The increasing utilisation of radiotherapy for treatment of cancer is resulting in growth for radiodermatitis market. Additionally, the factors such as growing awareness about radiodermatitis, increasing clinical trials for efficacy of various treatment products, and issuance of directives from various government and private organisation for better treatment and management of radiodermatitis will aid the growth of the market. The growing research and development in cancer treatment and controlling its side effects will further bolster the growth in the forecast period.